These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 9813029

  • 1. The interleukin-4 receptor activates STAT5 by a mechanism that relies upon common gamma-chain.
    Lischke A, Moriggl R, Brändlein S, Berchtold S, Kammer W, Sebald W, Groner B, Liu X, Hennighausen L, Friedrich K.
    J Biol Chem; 1998 Nov 20; 273(47):31222-9. PubMed ID: 9813029
    [Abstract] [Full Text] [Related]

  • 2. Activation of STAT5 by IL-4 relies on Janus kinase function but not on receptor tyrosine phosphorylation, and can contribute to both cell proliferation and gene regulation.
    Friedrich K, Kammer W, Erhardt I, Brändlein S, Sebald W, Moriggl R.
    Int Immunol; 1999 Aug 20; 11(8):1283-94. PubMed ID: 10421786
    [Abstract] [Full Text] [Related]

  • 3. Constitutive association of JAK1 and STAT5 in pro-B cells is dissolved by interleukin-4-induced tyrosine phosphorylation of both proteins.
    Erhardt I, Lischke A, Sebald W, Friedrich K.
    FEBS Lett; 1998 Nov 13; 439(1-2):71-4. PubMed ID: 9849880
    [Abstract] [Full Text] [Related]

  • 4. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA, Erwin RA, Wang L, Wang Y, Rui H, Farrar WL.
    J Immunol; 2000 Nov 01; 165(9):5097-104. PubMed ID: 11046040
    [Abstract] [Full Text] [Related]

  • 5. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.
    Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD.
    Proc Natl Acad Sci U S A; 1995 Sep 12; 92(19):8705-9. PubMed ID: 7568001
    [Abstract] [Full Text] [Related]

  • 6. Cloning of human Stat5B. Reconstitution of interleukin-2-induced Stat5A and Stat5B DNA binding activity in COS-7 cells.
    Lin JX, Mietz J, Modi WS, John S, Leonard WJ.
    J Biol Chem; 1996 May 03; 271(18):10738-44. PubMed ID: 8631883
    [Abstract] [Full Text] [Related]

  • 7. Delineation of the regions of interleukin-2 (IL-2) receptor beta chain important for association of Jak1 and Jak3. Jak1-independent functional recruitment of Jak3 to Il-2Rbeta.
    Zhu MH, Berry JA, Russell SM, Leonard WJ.
    J Biol Chem; 1998 Apr 24; 273(17):10719-25. PubMed ID: 9553136
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6.
    Pesu M, Takaluoma K, Aittomäki S, Lagerstedt A, Saksela K, Kovanen PE, Silvennoinen O.
    Blood; 2000 Jan 15; 95(2):494-502. PubMed ID: 10627454
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis.
    Bauer JH, Liu KD, You Y, Lai SY, Goldsmith MA.
    J Biol Chem; 1998 Apr 10; 273(15):9255-60. PubMed ID: 9535918
    [Abstract] [Full Text] [Related]

  • 13. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells.
    Demoulin JB, Uyttenhove C, Lejeune D, Mui A, Groner B, Renauld JC.
    Cancer Res; 2000 Jul 15; 60(14):3971-7. PubMed ID: 10919676
    [Abstract] [Full Text] [Related]

  • 14. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.
    Kirken RA, Rui H, Malabarba MG, Howard OM, Kawamura M, O'Shea JJ, Farrar WL.
    Cytokine; 1995 Oct 15; 7(7):689-700. PubMed ID: 8580378
    [Abstract] [Full Text] [Related]

  • 15. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation.
    Friedrich K, Wietek S.
    Biol Chem; 2001 Feb 15; 382(2):343-51. PubMed ID: 11308032
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
    Behbod F, Erwin-Cohen RA, Wang ME, Trawick BW, Qu X, Verani R, Kahan BD, Stepkowski SM, Kirken RA.
    J Immunol; 2001 Mar 15; 166(6):3724-32. PubMed ID: 11238613
    [Abstract] [Full Text] [Related]

  • 19. IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts.
    Rosenthal LA, Winestock KD, Finbloom DS.
    Cell Immunol; 1997 Nov 01; 181(2):172-81. PubMed ID: 9398404
    [Abstract] [Full Text] [Related]

  • 20. SOCS-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses STAT5 phosphorylation and lymphocyte proliferation.
    Cohney SJ, Sanden D, Cacalano NA, Yoshimura A, Mui A, Migone TS, Johnston JA.
    Mol Cell Biol; 1999 Jul 01; 19(7):4980-8. PubMed ID: 10373548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.